Purpose The Multicenter Study of Perioperative Ischemia (McSPI) AFRisk index predicts postoperative atrial fibrillation (POAF) after cardiac surgery, but requires pre-, intra-, and postoperative data. Other more abbreviated risk indices exist, but there is no consensus on which risk index is optimal. We compared the discriminatory capacity of the McSPI AFRisk index with three indices containing only preoperative data (the CHA 2 DS 2 Vasc score, POAF score, and Kolek clinical risk prediction model), hypothesizing that the McSPI AFRisk index would have superior predictive capacity. Methods We retrospectively evaluated 783 patients undergoing cardiac surgery using cardiopulmonary bypass. The predictive capacity of each index was assessed by comparing receiver-operating characteristic (ROC) curves, scaled Brier scores, net reclassification indices, and the integrated discrimination indices. 
moins extensifs, mais il n'y a pas de consensus sur le choix de l'indice optimal. Nous avons comparé la capacité de discrimination de l'indice McSPI AFRisk à celle de trois autres indices ne contenant que des données préopératoires (le score CHA 2 Postoperative atrial fibrillation (POAF) is the most common complication after cardiac surgery, 1 affecting 27-40% of patients and typically occurring in the first week after surgery. 2 Postoperative atrial fibrillation after cardiac surgery is associated with an increased risk for postoperative stroke, recurrent atrial fibrillation, myocardial infarction, longer intensive care unit (ICU) and hospital length of stay (LOS), higher healthcare costs, higher readmission rates, and increased mortality. [2] [3] [4] [5] Risk factors for POAF are well established and include advanced age, 2,6-10 history of atrial fibrillation (AF), 2, 6, 8, 9 valve surgery, 2,9 chronic obstructive pulmonary disease (COPD), 2, 9 left ventricular dysfunction, 6, 8, 9 left atrial enlargement, 10 11 has been shown to reliably predict the occurrence of POAF after coronary artery bypass graft (CABG) surgery, but requires pre-, intra-, and postoperative data. Recently, POAF risk scores that include only preoperative data have been proposed to be sufficient. Introduced in 2010 to predict the risk of thromboembolism in patients with atrial fibrillation, 12 the CHA 2 DS 2 VASc score has shown promise in predicting POAF after cardiac surgery in small-to moderate-size cohorts. [13] [14] [15] Similarly, the recently developed POAF score 9 and clinical riskprediction model developed by Kolek et al. 8 have shown predictive capacity in preliminary studies. While the POAF score has recently been found to outperform the CHA 2 DS 2 VASc score, 16 there is still no consensus on which index best predicts POAF. Determining which index has the best discriminative capacity would allow for improved individual risk stratification for POAF and the potential to better assess risk reduction in interventional studies. Additionally, identification of an accurate risk index would facilitate implementation of prophylactic measures, such as amiodarone administration, to reduce the incidence of POAF after cardiac surgery. 1 Because POAF increases morbidity, mortality, and healthcare costs, accurate risk assessment is important for instituting appropriate risk-reduction strategies. As such, we aimed to compare the predictive ability of the modified McSPI AFRisk index with three abbreviated indices containing only preoperative data, hypothesizing that the modified McSPI AFRisk index would have superior predictive capacity.
Methods
After obtaining approval from the Duke University School of Medicine Institutional Review Board (IRB Pro00006745, initially approved 13 March 2008), we retrospectively evaluated patients undergoing CABG ± valvular surgery in the Duke University Health System utilizing cardiopulmonary bypass (CPB) from 1994 to 2007 for whom comprehensive comorbidities, medications, and adverse outcomes had been prospectively collected. All included patients had consented to inclusion in a prospective observational database aimed at investigating phenotypic and genotypic differences that may be associated with adverse outcomes after cardiothoracic surgery. This database was collected with a target sample size of n = 1004 patients undergoing various cardiac surgical procedures and has been detailed in previous manuscripts. 17 A STROBE diagram detailing cohort selection is shown in Fig. 1 
Statistical analysis
The predictive capacity of each risk score was assessed using comparison of receiver-operating characteristic (ROC) curves, 18 scaled Brier scores, 19 as well as calculation of a net reclassification index (NRI) and integrated discrimination index (IDI). 20 For each ROC curve, the area under the curve (AUC) and the confidence intervals were estimated with generalized Mann-Whitney U statistics, and the differences between the AUCs were tested with Chi-squared tests. As point estimates and confidence intervals of risk index performance were of primary interest, the P values for the test of difference in the AUC were not corrected for the multiple pairwise comparisons. Brier scores, a measure of the accuracy of a probabilistic prediction, are defined as the average squared difference between the predicted probability and the patient's observed outcome. 21 Brier scores were calculated for each risk score and then scaled by the maximum possible score, given the observed incidence of POAF in this cohort, to create a scaled Brier score.
As each of the risk scores under consideration has defined risk strata, 2,8,9,12 we used net reclassification indices, a measure of improvement in risk classification with transition from one model to another, 22 to compare risk classification for each score relative to the modified AFRisk index. The calculation requires defining four probabilities based on reclassification to a higher risk class (moving ''up'') and reclassification to a lower risk class (moving ''down'') among patients who either did or
Adult Patients undergoing cardiac surgery included in observational database N=974
Eligible study population n=972 did not experience POAF. We defined patients as reclassified ''up'' if they moved from low risk in the comparison index to either moderate or high risk by the modified McSPI AFRisk index and reclassified ''down'' if they moved from high risk to either moderate or low risk by the modified McSPI AFRisk index. The NRI is estimated as the difference in proportion of events (patients with POAF) that were reclassified ''up'' vs ''down'' minus the difference in proportion of non-events (patients without POAF) reclassified ''up'' vs ''down''. In addition to comparing the risk classification we also calculated the IDI to assess the difference in discrimination between models across the possible range of cut points. 20 The IDI corresponds to the difference in discrimination slopes between the risk scores being compared and may be interpreted as the average improvement in risk values for events and non-events. 23 All analyses were performed using SAS TM version 9.4 (SAS Institute Inc, Cary, NC, USA) or R version 3.1.1. P\ 0.05 was considered statistically significant.
Study Cohort n=783

POAF status unknown n=2
ECG data unavailable
Results
The initial cohort included 972 patients undergoing cardiac surgery, but due to lack of availability of ECG data used to calculate the Kolek score, this was reduced to 783 patients whose demographics are depicted in Table 2 . The overall incidence of POAF was 32.6%, and the incidence of POAF in each risk group is depicted in Table 3 Receiver-operating characteristic curves for each index are depicted in Fig. 2 Reclassification data for the use of the modified McSPI AFRisk index compared with other risk scores are presented in Table 5 . Application of the modified McSPI AFRisk index to the CHA 2 DS 2 Vasc score resulted in a total NRI = 0.209, with the NRI for patients with POAF = 0.492 and the NRI for patients without POAF = -0.283. Application of the modified McSPI AFRisk index to the POAF score resulted in a total NRI = 0.034, with the NRI for patients with POAF = 0.508 and the NRI for patients without POAF = -0.474. Application of the modified McSPI AFRisk index to the Kolek clinical risk prediction model resulted in a total NRI = 0.120, with the NRI for patients with POAF = 0.467 and the NRI for patients without POAF = -0.347. As seen in Table 5 , the observed IDI was highest for the modified McSPI AFRisk index, indicating superior discrimination. By AUC difference and the NRI and IDI compared with the modified McSPI AFRisk index, the CHA 2 DS 2 Vasc score performed worst, and the POAF score was closest in performance although the modified McSPI AFRisk index had superior performance by every metric. The incidence of POAF in our study (32.6%) was similar to that seen in multiple previous cardiac surgical cohorts. 4, [8] [9] [10] 24 Of note, POAF has previously been reported as a relatively rare phenomenon (13% of patients), 13 perhaps related to regional variability in incidence. 2 Though not measured in our study, POAF has consistently been associated with increased in-hospital morbidity, 2, 5, 25, 26 resource utilization, 5,26,27 and short-term mortality 2,26 after cardiac surgery. In addition, patients experiencing POAF have an increased long-term risk of chronic atrial fibrillation 28 and decreased long-term survival after cardiac surgery. 7, 29 Importantly, strategies to reduce POAF have been associated with reduced hospital LOS, 4 healthcare costs, 4, 30 and incidence of stroke, 31 suggesting the importance of POAF as a major morbid event after cardiac surgery. Nevertheless, strategies to prevent POAF have not appreciably changed the incidence of POAF over the past decade. Better identification of at-risk patients may improve the efficiency and outcomes associated with preventive interventions.
Assessing the predictive capacity of multiple risk prediction models can be complex. The cornerstone of these comparisons is often based on ROC curves, which assess discrimination-the ability to determine who will develop the condition of interest. 20 Nevertheless, investigators have also encouraged the use of novel ways to evaluate the predictive capacity of risk models. 32 One such technique is the use of the NRI, which sums the correct vs incorrect risk reclassifications in moving from one model to another. 22 Based upon the derivation of the formula, 23 the NRI is flexible in quantifying differences between two-category (e.g., CHA 2 DS 2 Vasc score, Kolek clinical risk prediction model, and POAF score) and threecategory (e.g., modified McSPI AFRisk index) risk indices. To address a category-free measure of discrimination improvement, we also present the IDI, which can be used to quantify model improvement that may be missed by comparing AUCs. 20 Additionally, the overall performance 6 and increased comorbidity burden, respectively. The modified McSPI AFRisk index is unique in its inclusion of comprehensive medicationrelated data. The advent of complex electronic medical record systems can facilitate automated risk score derivation and provide timely risk stratification information to healthcare providers. While the literature has been mixed regarding the effects of perioperative angiotensin-converting enzyme (ACE) inhibitors, 33 both perioperative beta blockers 4 and statins 34 protect against the development of POAF. Interestingly, withdrawal of preoperative beta blockers or ACE-inhibitor therapy is associated with POAF, 2 a finding replicated in this cohort. It is likely that addition of these relevant medication-based factors improves the discriminative power of the modified McSPI AFRisk index.
The primary strength of this study is the prospective data collection and definition of POAF. Additionally, this represents an external validation of each risk index.
Limitations of this study include the use of a relatively homogeneous cohort of primarily Caucasian patients undergoing non-emergent cardiac surgery at a large tertiary medical center. These characteristics may limit the generalizability of our results to other populations. In addition, the overall approach of this study is a retrospective cohort analysis of patients undergoing surgery over a 13-year period, during which time cardiac surgical care may have advanced. Nevertheless, perioperative care as well as data collection strategies were standardized throughout this time period. Moreover, this manuscript does not account for post-discharge POAF, which occurs in the minority of patients after cardiac surgery but is less common than in-hospital POAF. 35 While this investigation does not address the negative impact of POAF on postoperative recovery profiles, this link has been well established in previous literature, with POAF associated with increased ICU and hospital LOS, higher costs, more frequent readmissions, higher perioperative and long-term mortality, and higher long-term risks of atrial dysrhythmias. 5, 26, 27 Finally, no single performance metric provides a comprehensive assessment of model performance, and both ROC curves 22 and the NRI 36 have been criticized for providing incomplete measures of performance. Nevertheless, the lack of overlap between AUC confidence intervals of the modified McSPI vs other indices provides a compelling indicator of superiority. In addition, we combined multiple measures to strengthen our ability to assess the performance of each risk index.
In conclusion, the modified McSPI AFRisk index showed improved ability to predict POAF compared with the CHA 2 DS 2 Vasc score, POAF score, and Kolek clinical risk prediction model. This may be due to the inclusion of medication-related information, which is unique to the modified McSPI AFRisk index. In future studies, investigators are encouraged to account for perioperative management of common cardiovascular medications, including beta blockers, ACE inhibitors, statins, and potassium supplementation, as these data may better elucidate the risk of POAF. Moreover, as electronic medical records become increasingly complex, physicians could integrate the modified McSPI AFRisk index into perioperative care of cardiac surgical patients, thereby potentially reducing medication withdrawal and so decreasing the incidence of POAF. Future research is necessary to determine the generalizability of our results to larger, more heterogeneous populations. As cardiovascular care advances and the surgical population continues to include older, frailer patients, prevention of POAF may prove to be an effective strategy to reduce perioperative morbidity and costs. Paramount to prevention is risk stratification or individual risk prediction, and further work should focus on optimizing the performance of these various POAF risk-prediction scores.
